Go offline with the Player FM app!
SELECT TRIAL: Semaglutide, Central Fat, and Cardioprotection 🧪🏹🛡️
Manage episode 515401786 series 2740117
🫀📉 Published in The Lancet (Oct 22, 2025): SELECT trial investigators report that semaglutide reduced MACE by 20% in patients with obesity but without diabetes—independent of weight loss. Waist circumference, not weight, tracked with outcomes, yet explained only 33% of the benefit. This landmark analysis redefines GLP-1RAs as disease-modifying agents, not just weight-loss drugs.
👉 Read here: https://doi.org/10.1016/S0140-6736(25)01375-3
#SELECTTrial #Semaglutide #Cardiovascular #Obesity #GLP1RA #TheLancet
757 episodes
Manage episode 515401786 series 2740117
🫀📉 Published in The Lancet (Oct 22, 2025): SELECT trial investigators report that semaglutide reduced MACE by 20% in patients with obesity but without diabetes—independent of weight loss. Waist circumference, not weight, tracked with outcomes, yet explained only 33% of the benefit. This landmark analysis redefines GLP-1RAs as disease-modifying agents, not just weight-loss drugs.
👉 Read here: https://doi.org/10.1016/S0140-6736(25)01375-3
#SELECTTrial #Semaglutide #Cardiovascular #Obesity #GLP1RA #TheLancet
757 episodes
Усі епізоди
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.


 
 
 
